Lenograstim Efficacy in Neutropenia Treatment
Neutropenia poses significant challenges in clinical settings. Lenograstim, a granulocyte colony-stimulating factor, has emerged as a viable therapeutic agent. It plays a crucial role in managing low white blood cell counts, particularly in oncology patients. The introduction of advanced diagnostic tools and therapies has increased interest in its efficacy. This article explores lenograstim’s role in …